Hepatobiliary Surgery — MCQs

Hepatobiliary Surgery Indian Medical PG Practice Questions and MCQs

Question 331: What is the treatment of choice for carcinoma of the head of the pancreas?

A. Radiotherapy
B. Chemotherapy plus radiotherapy
C. Whipple's surgery (Correct Answer)
D. Resection of the entire pancreas with adjuvant chemotherapy

Explanation: **Explanation:** **Whipple’s surgery (Pancreaticoduodenectomy)** is the gold standard and only potentially curative treatment for resectable carcinoma of the head of the pancreas. The procedure involves the removal of the pancreatic head, duodenum, gallbladder, distal common bile duct, and sometimes the gastric antrum, followed by reconstruction (Pancreaticojejunostomy, Hepaticojejunostomy, and Gastrojejunostomy). **Analysis of Options:** * **Option A & B:** Pancreatic adenocarcinoma is relatively **radioresistant**. While chemotherapy (e.g., FOLFIRINOX or Gemcitabine) and radiotherapy are used in neoadjuvant (to downstage tumors) or adjuvant settings, they are not the primary treatment of choice for resectable disease. * **Option D:** Total pancreatectomy is generally avoided due to the resulting "brittle diabetes" and severe exocrine insufficiency. It is only indicated if the tumor is multifocal or involves the entire gland. Adjuvant chemotherapy is standard *after* surgery, but the surgical choice remains the Whipple procedure. **High-Yield Clinical Pearls for NEET-PG:** * **Classic Presentation:** Painless, progressive jaundice with a palpable gallbladder (**Courvoisier’s Law**). * **Tumor Marker:** **CA 19-9** (used for monitoring recurrence, not screening). * **Resectability Criteria:** The absence of distant metastasis and no involvement of the Superior Mesenteric Artery (SMA) or Celiac axis. * **Most Common Complication:** Delayed gastric emptying; however, the **most dreaded** complication is a **pancreatic fistula**. * **Double Duct Sign:** Seen on ERCP/MRCP, showing simultaneous dilatation of the common bile duct and the pancreatic duct.

Question 332: Which of the following can be a complication of gallstones?

A. Pancreatitis
B. Choledocholithiasis
C. Acute cholecystitis
D. All of the above (Correct Answer)

Explanation: **Explanation:** Gallstones (cholelithiasis) can lead to a spectrum of complications depending on where the stone migrates and causes obstruction. 1. **Acute Cholecystitis:** This is the most common complication. It occurs when a gallstone becomes impacted in the **Cystic Duct**, leading to gallbladder distension, inflammation, and secondary infection. 2. **Choledocholithiasis:** This refers to the migration of gallstones from the gallbladder into the **Common Bile Duct (CBD)**. This can lead to obstructive jaundice or ascending cholangitis (Charcot’s Triad). 3. **Pancreatitis:** Specifically "Gallstone Pancreatitis," this occurs when a stone migrates further down the CBD and obstructs the **Ampulla of Vater** (or the common channel). This causes a reflux of bile or an increase in pancreatic ductal pressure, triggering intrapancreatic enzyme activation and inflammation. **Why "All of the above" is correct:** Since gallstones can obstruct the cystic duct, the CBD, or the pancreatic ductal system, they are a primary etiological factor for all three conditions listed. **High-Yield Clinical Pearls for NEET-PG:** * **Mirizzi Syndrome:** Extrinsic compression of the Common Hepatic Duct by a stone impacted in the cystic duct/Hartmann’s pouch. * **Gallstone Ileus:** A late complication where a large stone (usually >2.5 cm) creates a cholecysto-enteric fistula (most commonly with the duodenum) and causes mechanical bowel obstruction at the **ileocecal valve**. * **Saint’s Triad:** The co-existence of Cholelithiasis, Hiatus Hernia, and Diverticulosis. * **Boas’ Sign:** Hyperesthesia (increased sensitivity) below the right scapula, seen in acute cholecystitis.

Question 333: Which of the following is NOT a criterion for non-resectability in hilar cholangiocarcinoma?

A. Involvement of secondary biliary radicals bilaterally
B. Metastasis to celiac nodes
C. Involvement of the right branch of the portal vein (Correct Answer)
D. Contralateral involvement of the bile duct

Explanation: ### Explanation Hilar cholangiocarcinoma (Klatskin tumor) resectability is determined by the extent of local biliary involvement, vascular invasion, and distant metastasis. The goal of surgery is an **R0 resection** (microscopically negative margins). **Why Option C is the Correct Answer:** Involvement of the **right branch of the portal vein** is **not** a criterion for non-resectability. If a tumor involves the right hepatic duct and the right portal vein, it can still be resected via a **right hemi-hepatectomy**. Resectability is only compromised if there is involvement of the **main portal vein** or **bilateral** involvement of its branches (or contralateral involvement, e.g., right ductal involvement with left portal vein encasement). **Analysis of Incorrect Options (Criteria for Non-resectability):** * **Option A (Secondary biliary radicals bilaterally):** If the tumor extends to the secondary radicals on both sides (Bismuth-Corlette Type IV), it is generally considered unresectable because a tumor-free margin cannot be achieved while maintaining functional liver drainage. * **Option B (Metastasis to celiac nodes):** Hilar cholangiocarcinoma follows a specific lymphatic drainage. Involvement of N1 nodes (cystic duct, CBD, portal vein) is resectable, but **N2 nodes** (celiac, superior mesenteric, or para-aortic) are considered distant metastatic disease and signify unresectability. * **Option D (Contralateral involvement):** If a tumor involves the right-sided bile ducts but encases the left-sided portal vein or hepatic artery (and vice versa), it is unresectable because the "future liver remnant" would have no blood supply. **Clinical Pearls for NEET-PG:** * **Bismuth-Corlette Classification:** Type I (Common hepatic duct), Type II (Bifurcation), Type IIIa/b (Right/Left secondary radicals), Type IV (Bilateral secondary radicals). * **Investigation of Choice:** **MRCP** is the gold standard for mapping the biliary tree; **CT Angiography** is used to assess vascular invasion. * **Triad of Unresectability:** Bilateral ductal extension, bilateral vascular involvement, or atrophy of one lobe with contralateral vascular/ductal involvement.

Question 334: Which of the following constitutes Charcot's triad?

A. Fever, pain, and vomiting
B. Fever, stone, and jaundice
C. Fever, pain, and jaundice (Correct Answer)
D. Gall stone, vomiting, and jaundice

Explanation: **Explanation:** **Charcot’s Triad** is the classic clinical presentation of **Acute Cholangitis**, which is an infection of the biliary tree typically caused by an obstruction (most commonly gallstones or "choledocholithiasis"). The correct answer is **C (Fever, pain, and jaundice)**. The underlying pathophysiology involves two factors: **biliary obstruction** and **infected bile**. Obstruction increases intraductal pressure, allowing bacteria (commonly *E. coli*, *Klebsiella*) to enter the systemic circulation. This results in: 1. **Fever with chills:** Due to bacteremia. 2. **Right Upper Quadrant (RUQ) Pain:** Due to distension of the biliary tree. 3. **Jaundice:** Due to the backup of conjugated bilirubin into the bloodstream. **Analysis of Incorrect Options:** * **A & D:** While **vomiting** is common in biliary colic or cholecystitis, it is not a defining component of the diagnostic triad for cholangitis. * **B:** While a **stone** is the most common cause, the triad describes clinical *symptoms/signs* rather than the underlying etiology. **High-Yield Clinical Pearls for NEET-PG:** * **Reynolds’ Pentad:** If a patient with Charcot’s triad also develops **Hypotension (shock)** and **Altered Mental Status**, it is called Reynolds’ Pentad. This indicates obstructive suppurative cholangitis and is a surgical emergency. * **Diagnosis:** Ultrasound is the initial investigation; however, **ERCP** is the "Gold Standard" as it is both diagnostic and therapeutic (allows for biliary decompression). * **Management:** The priority is IV fluids and antibiotics, followed by urgent biliary drainage (usually via ERCP).

Question 335: This procedure is performed in which of the following conditions?

A. Mucocele
B. Mirizzi's syndrome
C. Xanthogranulomatous cholecystitis
D. Acalculous cholecystitis (Correct Answer)

Explanation: ***Acalculous cholecystitis*** - **Percutaneous cholecystostomy** is specifically indicated for acalculous cholecystitis in **critically ill** or **high-risk surgical patients** who cannot tolerate immediate surgery. - This minimally invasive procedure provides **temporary drainage** and symptom relief while the patient's condition stabilizes for potential future cholecystectomy. *Mucocele* - **Mucocele of the gallbladder** is a chronic condition requiring **elective laparoscopic cholecystectomy** as the definitive treatment. - Percutaneous drainage is **contraindicated** as it may lead to peritoneal contamination and does not address the underlying pathology. *Mirizzi's syndrome* - This condition involves **gallstone impaction** in the cystic artery causing **common hepatic duct compression** and requires **surgical exploration** and cholecystectomy. - **Complex surgical reconstruction** may be needed, making percutaneous cholecystostomy inappropriate as it doesn't address the biliary obstruction. *Xanthogranulomatous cholecystitis* - This **chronic inflammatory condition** with **dense adhesions** and **thickened gallbladder wall** requires **open cholecystectomy** due to surgical complexity. - Percutaneous drainage is **ineffective** as the condition involves chronic fibrosis and granulomatous inflammation that needs complete surgical removal.

Question 336: Extended cholecystectomy includes removal of all except:

A. Segment IVb & V of liver
B. Gall bladder
C. Peri-choledochal lymph node
D. Right hepatic bile duct (Correct Answer)

Explanation: **Explanation:** Extended cholecystectomy (also known as Radical Cholecystectomy) is the standard surgical treatment for localized Gallbladder Cancer (T1b to T3). The goal is to achieve an R0 resection by removing the gallbladder along with adjacent tissues that are most likely to be involved by direct extension or lymphatic spread. **Why Option D is correct:** The **Right hepatic bile duct** is not routinely removed in an extended cholecystectomy. Extrahepatic bile duct resection is only indicated if there is gross involvement of the duct, a positive cystic duct margin on frozen section, or if the tumor is located at the gallbladder neck/infundibulum involving the hilum. It is not a standard component of the procedure. **Analysis of incorrect options:** * **Gallbladder (Option B):** This is the primary organ of origin and the central component of the resection. * **Segment IVb & V of liver (Option A):** The gallbladder lies in the gallbladder fossa between these two segments. A wedge resection or formal segmentectomy of IVb and V (2–3 cm margin) is performed to ensure clear parenchymal margins. * **Peri-choledochal lymph node (Option C):** Regional lymphadenectomy is mandatory. This includes the cystic duct node (Lund’s/Mascagni’s), peri-choledochal, peri-portal, and retro-pancreatic nodes (Station 8, 12, and 13). **High-Yield Clinical Pearls for NEET-PG:** * **T1a tumors** (confined to mucosa) require only a simple cholecystectomy. * **T1b tumors** (involving muscle layer) and above require an **Extended Cholecystectomy**. * The **Nodal Status** is the most important prognostic factor in gallbladder cancer. * The **Node of Lund** (cystic duct node) is the first-level lymph node involved. * If a laparoscopic cholecystectomy incidentally reveals cancer, the **port sites** should generally not be excised (current guidelines) unless specifically involved.

Question 337: What is the PAIR technique for the treatment of hydatid disease of the liver?

A. Punchure albendazole irrigation regimen
B. Puncture aspiration injection reaspiration technique (Correct Answer)
C. Praziquantel Albendazole injection reaspiration technique
D. Partial resection of affected organ (liver)

Explanation: **Explanation:** The **PAIR technique** is a minimally invasive percutaneous treatment modality for cystic echinococcosis (hydatid disease) caused by *Echinococcus granulosus*. **1. Why the correct answer is right:** The acronym **PAIR** stands for: * **P (Puncture):** Percutaneous puncture of the cyst using a needle or catheter under ultrasound or CT guidance. * **A (Aspiration):** Aspiration of the cyst fluid (hydatid sand) to reduce internal pressure. * **I (Injection):** Injection of a **scolicidal agent** (commonly 20% hypertonic saline or 95% ethanol) into the cyst for at least 15–30 minutes to kill the germinal layer. * **R (Reaspiration):** Final aspiration of the fluid to prevent chemical cholangitis. **2. Why the incorrect options are wrong:** * **Option A & C:** While Albendazole and Praziquantel are essential adjuvant pharmacotherapies, they are administered orally, not via "injection" or "irrigation" as part of the procedural acronym. * **Option D:** Partial resection (e.g., hepatectomy) is a radical surgical approach, not the PAIR technique. **3. High-Yield Clinical Pearls for NEET-PG:** * **Indications:** Best for WHO Stage **CE1 and CE3a** (unilocular cysts >5cm). * **Contraindications:** Do not perform PAIR for **CE2 and CE3b** (multiloculated/daughter cysts) or if there is a suspected **biliary communication** (risk of sclerosing cholangitis). * **Prophylaxis:** Always start **Albendazole** (10-15 mg/kg/day) at least 4 days before and continue for 4 weeks after the procedure to prevent secondary hydatidosis from accidental spillage. * **Complication:** The most feared immediate complication is **anaphylaxis** due to fluid leakage.

Question 338: Which condition is characterized by sclerosis of the bile duct?

A. Primary sclerosing cholangitis (Correct Answer)
B. Obstructive jaundice
C. Bile duct atresia
D. Bile stones

Explanation: **Explanation:** **Primary Sclerosing Cholangitis (PSC)** is the correct answer because it is a chronic, progressive cholestatic liver disease characterized by inflammation, fibrosis, and **obliterative sclerosis** of both intrahepatic and extrahepatic bile ducts. This leads to the classic "beaded appearance" on imaging (MRCP/ERCP) due to alternating segments of stricture and dilation. **Analysis of Incorrect Options:** * **Obstructive Jaundice:** This is a clinical sign/syndrome, not a specific disease. While PSC causes obstructive jaundice, the jaundice itself is a result of the blockage, not the underlying process of ductal sclerosis. * **Bile Duct Atresia:** This is a congenital neonatal condition characterized by the complete absence or fibro-obliteration of the biliary tree. While it involves fibrosis, it is a developmental failure/obliteration rather than the progressive "sclerosis" seen in adult inflammatory conditions like PSC. * **Bile Stones (Choledocholithiasis):** These cause mechanical obstruction. While chronic irritation from stones can lead to secondary cholangitis or strictures, the primary pathology is intraluminal obstruction, not a primary sclerosing process of the ductal wall. **High-Yield Clinical Pearls for NEET-PG:** * **Association:** Strongly associated with **Inflammatory Bowel Disease (IBD)**, specifically Ulcerative Colitis (approx. 70-80% of PSC patients have UC). * **Imaging Gold Standard:** MRCP showing the **"Beaded Appearance."** * **Antibody Marker:** Often positive for **p-ANCA**. * **Malignancy Risk:** Significantly increased risk of **Cholangiocarcinoma** (10-15% lifetime risk). * **Histology:** Classic **"Onion-skin fibrosis"** (periductal concentric fibrosis).

Question 339: A 45-year-old female presents with symptoms of acute cholecystitis. Ultrasound shows a solitary gallstone measuring 1.5 cm. Symptoms are controlled with medical management. Which of the following is the next most appropriate step in the management of this patient?

A. Regular follow-up
B. Intravenous antibiotics
C. Laparoscopic cholecystectomy immediately (Correct Answer)
D. Open cholecystectomy immediately

Explanation: **Explanation:** The patient presents with **symptomatic gallstone disease** (acute cholecystitis). The standard of care for symptomatic cholelithiasis, especially when presenting as acute cholecystitis, is surgical intervention. **1. Why Option C is Correct:** **Laparoscopic cholecystectomy** is the gold standard treatment for symptomatic gallstones. Current guidelines (Tokyo Guidelines 2018) recommend **early laparoscopic cholecystectomy** (ideally within 72 hours of symptom onset) for acute cholecystitis. Even if symptoms are medically controlled, the gallbladder is now "diseased," and there is a high risk of recurrent attacks or complications (empyema, perforation, or gallstone ileus) if the gallbladder is not removed. **2. Why Other Options are Incorrect:** * **Option A (Regular follow-up):** This is reserved for *asymptomatic* (silent) gallstones. Once a patient becomes symptomatic, the risk of complications increases significantly, making surgery mandatory. * **Option B (IV Antibiotics):** While antibiotics are part of the initial medical management to stabilize the patient, they are not a definitive cure. Relying solely on antibiotics without surgery leads to high recurrence rates. * **Option D (Open cholecystectomy):** While a valid surgical approach, it is no longer the first-line choice. Laparoscopy is preferred due to less postoperative pain, shorter hospital stays, and faster recovery. Open surgery is now typically reserved for difficult cases where laparoscopy is contraindicated or needs to be converted. **Clinical Pearls for NEET-PG:** * **Indications for surgery in asymptomatic gallstones:** Stone >3 cm, porcelain gallbladder, gallbladder polyps >1 cm, or stones in patients with hemolytic anemia (e.g., Sickle cell). * **Timing:** "Early" cholecystectomy (within 72 hours) is superior to "delayed" cholecystectomy (6–8 weeks later) in terms of total hospital stay and cost, without increasing the risk of bile duct injury. * **Investigation of Choice:** Ultrasound is the initial and best screening tool for gallstones (high sensitivity/specificity).

Question 340: What is the treatment of choice for silent stones in the gallbladder?

A. Observation (Correct Answer)
B. Chenodeoxycholic acid
C. Cholecystectomy
D. Lithotripsy

Explanation: **Explanation:** The treatment of choice for **silent (asymptomatic) gallstones** is **observation (expectant management)**. Most patients with asymptomatic gallstones remain symptom-free throughout their lives; the risk of developing symptoms or complications is only about 1–2% per year. Since the risks associated with surgery (anesthesia, bile duct injury) outweigh the low risk of developing complications like acute cholecystitis or pancreatitis, prophylactic surgery is not indicated. **Why other options are incorrect:** * **Chenodeoxycholic acid:** This is a form of medical dissolution therapy. It is rarely used today because it is only effective for small, non-calcified cholesterol stones, requires a functioning gallbladder, and has a high recurrence rate once the drug is stopped. * **Cholecystectomy:** This is the treatment of choice for **symptomatic** gallstones. Prophylactic cholecystectomy for silent stones is only reserved for specific high-risk groups (see Clinical Pearls). * **Lithotripsy (ESWL):** Extracorporeal Shock Wave Lithotripsy is largely obsolete for gallstones due to high recurrence rates and the superiority of laparoscopic cholecystectomy. **Clinical Pearls for NEET-PG:** While observation is the rule, **prophylactic cholecystectomy** for silent stones is indicated in: 1. **Porcelain gallbladder** (high risk of gallbladder carcinoma). 2. **Large stones (>3 cm)** or stones in a gallbladder with a **congenital anomaly**. 3. **Gallbladder polyps >10 mm** or polyps associated with stones. 4. Patients undergoing **bariatric surgery** or organ transplantation. 5. **Sickle cell anemia** (to avoid confusion between a sickle crisis and cholecystitis). 6. **Pancytopenia** or long-term hemolytic states.

Practice by Chapter

Liver Anatomy and Physiology

Practice Questions

Benign Liver Lesions

Practice Questions

Liver Abscess

Practice Questions

Hepatocellular Carcinoma

Practice Questions

Metastatic Liver Disease

Practice Questions

Cirrhosis and Portal Hypertension

Practice Questions

Liver Trauma

Practice Questions

Cholelithiasis and Cholecystitis

Practice Questions

Choledocholithiasis

Practice Questions

Biliary Tract Tumors

Practice Questions

ERCP and Its Complications

Practice Questions

Liver Transplantation Basics

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free